The excitement surrounding the ability to measure genomic, epigenomic, transcriptomic, and metabolic status in individual cells is reflected in the high level of commercial activity we’ve seen this year. Our editorial staff at Instrument Business Outlook are constantly scanning the market to identify hot spots of activity that help inform our report publication strategy. Such […]
